DISORDER
MECHANISM
FEATURES · LABS
CLUE · TREATMENT
Cushing syndrome — features
Excess cortisol: catabolic, gluconeogenic, immunosuppressive, mineralocorticoid at high levels
Central obesity, moon face, buffalo hump, wide purple striae, thin skin, bruising, proximal myopathy, HTN, hyperglycemia, osteoporosis, infections, depression
Androgen signs (hirsutism, acne) if ACTH-driven
Exogenous glucocorticoids
most common
Suppressed CRH/ACTH
↓ ACTH, bilateral adrenal atrophy
Taper slowly — abrupt stop → adrenal crisis
Cushing disease
most common endogenous
Pituitary ACTH microadenoma → bilateral adrenal hyperplasia
↑ ACTH; cortisol suppresses with high-dose dexamethasone; ↑ ACTH with CRH
Transsphenoidal surgery · IPSS localizes
ACTH from small cell lung cancer, bronchial carcinoid, medullary thyroid, pancreatic NET
↑↑ ACTH, no suppression; rapid onset, hypokalemic alkalosis, hyperpigmentation, weight loss
Look in the chest
Adrenal adenoma / carcinoma
Autonomous cortisol production
↓ ACTH, contralateral atrophy; carcinoma: large mass, mixed cortisol + androgen excess (virilization)
Adrenalectomy
Confirm excess, then localize
Screen: 24-h urine free cortisol, late-night salivary cortisol, 1 mg overnight dex → measure ACTH → high-dose dex, CRH test, IPSS, imaging
Image only after biochemical localization
Primary hyperaldosteronism
Bilateral adrenal hyperplasia (most) or aldosterone-producing adenoma (Conn)
Resistant HTN, hypokalemia (may be normal), metabolic alkalosis, no edema (aldosterone escape); ↑ aldosterone, ↓ renin
↑ aldosterone:renin ratio → saline suppression → adrenal vein sampling
Primary aldosteronism — treatment
Block or remove the source
Unilateral adenoma → adrenalectomy · bilateral hyperplasia → spironolactone or eplerenone
Spironolactone → gynecomastia
Secondary hyperaldosteronism
↑ renin drives aldosterone: renal artery stenosis (fibromuscular dysplasia in young women, atherosclerosis in older), HF, cirrhosis, renin-secreting tumor
↑ renin, ↑ aldosterone; renal bruit in RAS
ACE inhibitor → AKI in bilateral RAS
Glucocorticoid-remediable aldosteronism
Chimeric CYP11B1/CYP11B2 → ACTH drives aldosterone synthase (AD)
Early-onset HTN, family history of early stroke
Dexamethasone suppresses
Low-renin, low-aldosterone HTN
11β-HSD2 deficiency or licorice (cortisol acts on MR) · Liddle (ENaC gain of function) · 11β- or 17α-hydroxylase CAH
HTN, hypokalemia, alkalosis with both renin and aldosterone ↓
Liddle → amiloride or triamterene